MAPT and amyloidosis: CSF biomarker measurements positive for tau pathology but negative for amyloid pathology may seem suggestive of primary age-related tauopathy (PART) (68), but recent research suggests increased soluble CSF p-tau is more closely correlated with amyloid deposition than tau neurofibrillary tangles as measured through PET imaging (69, 70).